GoodRx Under Scrutiny: Antitrust Class Actions Spotlight Alleged Price-Fixing Agreements with PBMs

In recent legal developments, GoodRx is facing a series of antitrust class actions filed in federal courts in California and Rhode Island. These lawsuits allege that GoodRx has engaged in an unlawful price-fixing agreement. Specifically, the complaints assert that GoodRx, in collaboration with several pharmacy benefit managers (PBMs) including CVS, Express Scripts, MedImpact, and Navitus, orchestrated efforts to artificially suppress the prices paid to independent pharmacies for generic drugs. This alleged agreement, noted in a complaint filed on November 1 in the U.S. District Court for the Central District of California, has raised significant concerns among independent pharmacy operators who claim that such practices undermine competitive pricing dynamics in the pharmaceutical market. For further details, visit the full article.